Aldeyra Therapeutics's total assets for Q3 2025 were $77.80M, a decrease of -8.43% from the previous quarter. ALDX total liabilities were $28.56M for the fiscal quarter, a -3.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.